Back
Corvus Pharmaceuticals 10K Form
Buy
58
CRVS
Corvus Pharmaceuticals
Last Price:
8.94
Seasonality Move:
-3.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRVS News And Ratings
See the #1 stock for the next 7 days that we like better than CRVS
CRVS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-6.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.20 |
| Price / Book: | 46.29 |
Profitability
| EPS (TTM): | -0.92000 |
|---|---|
| Net Income (TTM): | $-56.83M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Corvus Pharmaceuticals Earnings Forecast
Key Corvus Pharmaceuticals Financial Ratios
- The Interest Expense is -0.05% of Operating Income.
- Per Share Earnings over the last 9 years have been positive in 5 years.
Corvus Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRVS |
| CUSIP: | 221015 |
| Website: | corvuspharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CRVS Technical Analysis vs Fundamental Analysis
Buy
58
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a Buy
The current Corvus Pharmaceuticals [CRVS] share price is $8.94. The Score for CRVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.